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Abstract  
 
Objective:  Determine if anteroposterior genital hiatus (GH) widening obscures rather than 
facilitates signs and symptoms, inadvertently altering management decisions for women with 
pelvic organ prolapse during Valsalva’s maneuver, at a given total vaginal length (TVL).  
Methods:  We performed a retrospective cohort with nested cross-sectional study of patients 
who underwent pelvic organ prolapse (POP) surgery. Data from obstetric and gynecologic 
history, pre- and postoperative physical examinations, and PFDI-20 and PFIQ-7 scores were 
extracted. Study participants were compared in 2 groups:  Anteroposterior widened (> 3 cm) 
and not widened (< 3 cm) GH, for baseline leading edge (LE), and POP stage, while controlling 
for TVL. Baseline PFDI-20 and PFIQ-7 scores were evaluated within GH groups. Delta GH, 
PFDI-20 and PFIQ-7 scores after apical suspension with and without posterior colporrhaphy 
were compared to assess the clinical value of the procedure. 
Results:  Study participants with anteroposterior GH widening during Valsalva’s maneuver had 
greater baseline LE descent and higher POP stage than those without anteroposterior GH 
widening after controlling for TVL. Baseline PFDI-20 and PFIQ-7 scores were similar within 
both GH categories controlling for prolapse severity. Adding posterior colporrhaphy to apical 
suspension resulted in a greater anteroposterior GH reduction without improving delta PFDI-20 
or PFIQ-7 scores. 
Conclusion:  Facilitation through herniation rather than obscuration from anteroposterior GH 
widening explains why patients will not be undertreated based on signs and symptoms of 
disease.  Adding posterior colporrhaphy to apical suspension more effectively reduces 
anteroposterior GH widening without differential improvement in symptoms rendering the 
operation to no more than a cosmetic procedure. 
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Single Sentence summary 
Connective tissue repairs effectively reduce anteroposterior GH widening without providing 
differential improvement in symptom bother and impact on activities of daily living because 
they are incapable of restoring obstetric-related levator ani muscle damage. 
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Introduction 
 
Pelvic organ prolapse (POP) is a common condition that affects millions of women 
worldwide, with 1 in 4 women reporting at least one pelvic floor disorder.1-2  Women have a 
12.6% lifetime risk of needing surgery for POP.3 Approximately 200,000 inpatient surgical 
procedures for prolapse are performed annually in the United States.4-5  
POP is diagnosed during physical examination using a staging system, most commonly 
the Pelvic Organ Prolapse Quantitation (POP-Q) system because it is objective, site-specific, 
and reliable.6 Two POP-Q measurement points are the genital hiatus (GH) and perineal body 
(PB). GH is measured sagitally from the external urethral meatus to the posterior fourchette of 
the vagina using a ruler. Translabial ultrasound has also been used to measure GH in the 
POP-Q quantification system.7-9 
Increasing GH size has been associated with greater POP, with GH ≥ 3.75 cm being 
predictive of apical support loss.10 Studies have reported vaginal delivery as a risk factor for 
GH widening11 due to traumatic injury to the levator muscles during childbirth.12-14 Widened GH 
has been linked to increased risk of POP recurrence, likely related to persistent levator ani 
damage after surgical repair.15-16 A wide urogenital hiatus has also been associated with an 
increased risk of early postoperative emptying disorders after POP surgical repair.17 In multiple 
studies, widened GH measurements were linked to a decreased chance of pessary retention, 
a nonsurgical intervention for POP.18-20 Evidently GH measurements have an important 
predictive value, making its inclusion in the POP-Q quantification system vital to the care of 
women with pelvic organ prolapse.   
Anteroposterior GH widening as a consequence of traumatic obstetric injury is evident 
on examination during Valsalva maneuver. Anteroposterior GH widening appears to consume 
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vaginal topography (Figure 1, x-axis) at the expense of leading edge (LE) descent (Figure 1, y-
axis) in select patients on pelvic examination during Valsalva’s maneuver.  We were therefore 
concerned that at a given vaginal length, anteroposterior GH widening might obscure descent 
of the leading edge and therefore prolapse stage, resulting in differences in symptom severity, 
and impact on activities of daily living.  This might inadvertently alter management decisions by 
health care providers for women with pelvic organ prolapse.  For example, patients with a 
leading edge of 0 may be “inoperable21”, while a leading edge of +1 to +2 may receive a 
uterosacral ligament suspension, and a leading edge ≥ +3 may receive obliterative or mesh 
augmented apical suspension because preoperative prolapse stage is a predictor of 
symptomatic recurrence22-24. 
We were unable to identify any existing research to allay our concerns. Our primary 
study objective was to design a study to test the null hypothesis that there would be no 
difference in baseline descent of the leading edge and therefore stage of prolapse, resulting in 
differences in symptom severity, and impact on activities of daily living controlling for prolapse 
stage for women with anteroposterior GH widening compared to those without anteroposterior 
GH widening during Valsalva’s maneuver at a given vaginal length.  
Surgical procedures designed to resolve POP and thus alter GH often involve posterior 
repair. The symptomatic value of posterior colporrhaphy at the time of POP surgery has 
reemerged as an inquiry of interest.25 Our secondary study objective was to design a study to 
test the null hypothesis that there would be no differential change in symptom severity and 
impact on activities of daily living changes despite changes in GH and PB measurements 
when comparing prolapse repairs with and without posterior colporrhaphy. 
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Methods 
We generated a computerized convenience sample list of  patients who underwent POP 
surgical repair from an academic tertiary office from January 2009 and February 2015 using 
Current Procedural Terminology (CPT) codes 57425, 57120, 57282, 57283, 57110, and 
58280.  We chose a convenience sample because there was no data from the medical 
literature to calculate an a priori sample size to confidently accept our null hypothesis of no 
effect of anteroposterior GH widening on LE descent at a given vaginal length or PFDI/PFIQ  
at a given stage of prolapse.   Postoperative examinations, symptom bother and impact on 
activities of daily living assessments were obtained from the last recorded visit between 6 
weeks and 18 months from date of surgery.  
The POP surgical procedures included reconstructive (vaginal and laparoscopic) and 
obliterative approaches. All surgeries are typically performed within 30 days of preoperative 
POP-Q assessments minimizing the likelihood of disease progression prior to treatment.  Two 
fellowship trained Urogynecology attendings with over 20 years of surgical experience directly 
supervised fellows in the performance of all surgical procedures. 
An IRB approval was obtained and data was collected from medical records (electronic 
and paper). Data included basic demographics such as age, body mass index (BMI), race, and 
parity. Clinical data included history of operative delivery, laceration during delivery, pertinent 
past surgical history (including colporrhaphy, apical suspension procedures, and 
hysterectomy), preoperative POP-Q measurement, POP surgery type and date, date of last 
follow up visit, and postoperative POP-Q measurement.  
POP-Q measurements during Valsalva’s maneuver in the supine position were 
collected at the initial visit and each follow up visit. Standing examination was reserved for 
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patients whose maximum vaginal wall descent based on patient recollection could not be 
demonstrably reproduced while supine. We defined the first visit examination as the 
preoperative POP-Q measurement and the last follow up visit as the postoperative POP-Q 
measurement, performed either by the fellow or attending physician of record. Patients were 
instructed to follow up at 6 weeks, 3, 6, 12, and 24 months postoperatively. The follow-up 
interval was defined as the time from surgery to the last postoperative visit recorded. 
 Responses from PFDI-20 and PFIQ-7 questionnaires were also collected to measure 
baseline and changes in symptom bother and impact on activities of daily living, respectively 
(delta scores = postoperative - preoperative scores, resulting in negative delta scores when 
interventions resulted in a decrease in symptom bother or improvement in impact on activities 
of daily living, respectively). Delta GH was calculated as the anteroposterior postoperative –
preoperative measurements in centimeters resulting in a negative delta measurement when 
interventions resulted in an anteroposterior decrease or narrowing of the GH width.  Delta PB 
was calculated as anteroposterior postoperative - preoperative measurements in centimeters 
resulting in a positive delta measurement when interventions resulted in an anteroposterior 
increase or lengthening of PB width.  
Primary objective through nested cross sectional study  
Patients were categorized into 2 groups based on anteroposterior GH size:  widened 
GH, defined as > 3 cm, and not widened GH, defined as ≤ 3 cm, based on a compromise 
between the inflection point data for length of the anterior vaginal wall exposed to intra-
abdominal wall pressure during Valsalva’s maneuver and the GH width predictive of apical 
support loss10,26.  Leading edge of prolapse (LE), and therefore POP-Q stage, was used to 
establish POP severity. Baseline differences in LE and POP-Q stage between GH groups 
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while controlling for preoperative total vaginal length (TVL) measurement were evaluated using 
χ2 test for association. TVL was controlled by stratification into 3 categories: <10 cm, 10 cm, 
and >10 cm, based on the TVL frequency distribution of our data.  
Differences in symptom bother and impact on ADLs between the two GH groups while 
controlling for POP stage were also evaluated using χ2 test for association. POP-Q stage was 
controlled by stratification into 2 categories:  a) Stages 0, 1, and 2, and b) Stages 3 and 4, 
based on POP-Q frequency distribution of our data.  Anteroposterior GH measurements were 
correlated with LE of prolapse to examine physiologic mechanisms for our findings using 
Pearson’s correlation coefficients.  
Secondary objective through retrospective (mesh augmented apical suspension) cohort 
study 
We determined the symptomatic value of performing abdominovaginal posterior 
colporrhaphy preceding laparoscopic sacrocolpoperineopexy compared to laparoscopic 
sacrocolpopexy with and without posterior colporrhaphy by examining the differential impact of 
surgical choice on delta PFDI-20, PFIQ-7, CRADI-8, and,CRAIQ-7 as measures of pelvic floor 
and colorectal symptom bother and impact on activities of daily living affected by changes in 
delta GH and PB measurements.  Surgery type was categorized as follows:  Mesh augmented 
apical suspension procedures were categorized as conventional laparoscopic 
sacrocolpoperineopexy (LSCP) when an abdominovaginal posterior colporrhaphy without 
levator plication was performed prior to anterior, posterior, apical vaginal and sacral 
attachment of mesh. The first stage included a vaginal dissection where a traditional posterior 
colporrhaphy without levator plication was augmented by the overlaid distal LSCP posterior 
mesh leaflet attached to the Iliococcygeal fascia laterally and the perineal body distally. The 
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second stage included attaching the mesh to the posterior vaginal wall laparoscopically in the 
standard technique. Procedures were categorized as conventional laparoscopic 
sacrocolpopexy (LSC) when traditional posterior colporrhaphy without levator plication or no 
posterior colporrhaphy were performed based on the surgeon's examination of the patient’s 
anatomy after apical suspension with anterior, posterior, apical vaginal, and sacral attachment 
of mesh.  
 Secondary objective through retrospective (native tissue apical suspension) cohort 
study 
We subsequently determined the symptomatic value of performing native tissue apical 
suspensions compared to a mesh augmented apical suspension and obliterative surgeries, 
when a posterior colporrhaphy was performed, by examining the differential impact of surgical 
choice on delta PFDI-20, PFIQ-7, CRADI-8, and CRAIQ-7 as measures of pelvic floor and 
colorectal symptom bother and impact on activities of daily living affected by changes in delta 
GH and PB measurements. Native tissue apical suspension procedures were categorized as 
laparoscopic uterosacral ligament suspension (LUSLS) and vaginal uterosacral ligament 
suspension (VUSLS). Obliterative procedures included total vaginectomy with levator plication 
and Lefort colpocleisis. Analysis of Variance (ANOVA) with Bonferroni’s test of significance for 
multiple comparisions was used to compare means for k groups where indicated both 
restrospective cohorts.  We analyzed the clinical significance of vaginal topographic restoration 
by comparing delta GH to delta PFDI-20, PFIQ-7, CRADI-8, and CRAIQ-7 as measures of 
pelvic floor and colorectal symptom bother and impact on activities of daily living, respectively, 
using Pearson’s correlation coefficients in both retrospective cohorts.  
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Normality of the frequency distributions was assessed by visual inspection of the 
histograms for all analyzed variables.  All statistical analyses were performed using SPSS 
v21.0 (IBM Corp, Armonk, NY). A p-value less than 0.05 was considered significant for all two-
tailed statistical comparisons.  
Results 
Eleven thousand one hundred and fifty nine patients underwent POP surgical repair 
from an academic tertiary office from January 2009 and February 2015.  Six hundred and 
eighteen patients who had pre- and postoperative physical exams and at least preoperative 
PFDI-20 and PFIQ-7 scores were included as study subjects.  Postoperative Pelvic Floor 
Distress Inventory (PFDI-20) and Pelvic Floor Impact Questionnaire (PFIQ-7) data were 
available in 203 of 618 (33%) study subjects.  These 618 study subjects had a mean age of 
60.5, mean BMI 29.0, mean parity 2.8 (median 3), and a mean follow-up length of 9.8 months 
(range 1.1 to 53.1 months).  Table 1 shows the demographics by GH group. 212 patients 
underwent LSCP, 176 patients underwent LSC, 77 underwent LUSLS, 96 underwent VUSLS, 
and 53 underwent obliterative procedures (4 patients had surgery type missing).  
Primary objective through nested cross sectional study  
Patients with preoperative anteroposterior GH widening had greater baseline LE of 
prolapse and therefore higher POP-Q stage compared to patients without anteroposterior GH 
widening, at a given vaginal length during Valsalva’s maneuver. This was statistically 
significant across all 3 TVL categories as shown in Table 2. We found no difference in baseline 
PFDI-20 and PFIQ-7 scores when comparing patients with anteroposterior GH widening to 
those without anteroposterior GH widening across both prolapse stage categories during 
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Valsalva’s maneuver (Table 3).  Anteroposterior  GH width was linearly associated with greater 
baseline LE of prolapse (r = 0.45, p <0.001).   
Secondary objective through retrospective (mesh augmented apical suspension) cohort 
study 
Both patients who underwent abdominovaginal posterior colporrhaphy without levator 
plication preceding LSCP (-2.2 ± 1.6) and those who underwent LSC followed by posterior 
colporrhaphy without levator plication (-2.0 ± 1.2) had a greater reduction in delta GH without a 
compensatory increase in delta PB compared to patients who underwent LSC without posterior 
colporrhaphy (-1.3 ± 1.1) at the time of POP repair (Table 4).  
There was no difference in delta PFDI-20 (-67.2 ± 50.7 vs. -57.9 ± 48.6 vs. -78.1 ± 33.9, 
p = 0.27), delta PFIQ-7 (-53.2 ± 59.8 vs. -40.5 ± 64.8 vs. -66.7 ±70.7, p = 0.27), delta CRADI (-
11.7 ± 19.4 vs. -18.6 ± 26.8 vs.-8.5 ± 15.3, p = 0.07),  or delta CRAIQ (-14.4 ± 22.8 vs. -17.3 ± 
32.6 vs. -16.7 ± 24.7, p = 0.58) reported by study subjects receiving LSCP, LSC without 
posterior colporrhaphy, and LSC with posterior colporrhaphy without levator plication, 
respectively.   
Secondary objective through retrospective (native tissue apical suspension) cohort 
study 
Patients who underwent vaginectomy with levator plication (-3.5 ± 2.5) had a greater 
reduction in delta GH compared to those who underwent conventional LSC (-2.0 ± 1.2), 
conventional LUSLS (-1.5 ± 1.2), and conventional VUSLS (-1.5 ± 1.5), when a posterior 
colporrhaphy was performed.  Delta GH after conventional LSC was greater than after either 
conventional LUSLS or VUSLS, when a posterior colporrhaphy was performed, although the 
mean difference between the groups did not meet our statistical threshold (mean difference -
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0.5, p = 0.1). Vaginectomy with levator plication resulted in a greater increase in PB size (1.3 ± 
1.4) compared to conventional LSC (0.3 ± 1.3, conventional LUSLS (-0.1 ± 1.5), and VUSLS 
(0.3 ± 1.7), when a posterior colporrhaphy was performed. There was no difference in delta 
PFDI-20 (-78.1 ± 33.9 vs. -79.7 ± 40.9 vs. -79.3 ± 63.2 vs. -90.6 ± 47.0, p = 0.08) , delta PFIQ-
7 (-66.7 ± 70.7 vs. -89.3 ± 64.3 vs. -64.4 ± 63.6 vs. -83.5 ± 69.5, p = 0.63),  delta CRADI (-8.5 
± 15.3 vs. -11.8 ± 11.8 vs. -13.2 ± 22.7 vs. -20.2 ± 16.2, p = 0.77), , or delta CRAIQ (-16.7 ± 
24.7 vs. -20.3 ± 30.7 vs. -14.0 ± 26.0 vs. -8.5 ± 11.5, p = 0.82) reported by study subjects 
receiving posterior colporrhaphy concomitantly with when posterior colporrhaphy was 
performed concomitantly with LSC, LUSLS, VUSLS, and vaginectomy with levator plication, 
respectively.     
Delta GH was weakly associated with delta PFIQ-7 (r = 0.16, p = 0.04), but was not 
associated with any difference in delta PFDI-20 (r = -0.01, p = 0.86), delta CRADI (r = 0.01, p = 
0.92), or delta CRAIQ (r = 0.11, p = 0.13). 
 
Discussion 
 
Greater genital hiatus size has been evaluated in multiple studies as a predictor of 
unsuccessful pessary retention,18-20 POP recurrence,16 and apical support loss.15 
Anteroposterior GH widening appears to consume vaginal topography at the expense of 
leading edge (LE) descent in select patients on pelvic examination during Valsalva’s 
maneuver.  We were concerned that at a given vaginal length, anteroposterior GH widening 
might obscure LE descent and therefore prolapse stage, resulting in differences in symptom 
severity, and impact on activities of daily living compared to patients without anteroposterior 
GH widening.  This might inadvertently altering management decisions by health care 
providers for women with pelvic organ prolapse.  
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Our study results are reassuring in proving our concerns unwarranted. Patients with 
anteroposterior GH widening had greater baseline LE descent and therefore higher stage of 
POP without changes in baseline PFDI-20 and PFIQ-7 scores controlling for prolapse stage 
compared to those without anteroposterior GH widening allowing us to reject our null 
hypothesis for our nested cross sectional study. Adding posterior colporrhaphy to apical 
suspension resulted in a greater anteroposterior GH reduction without differentially improving 
PFDI-20 or PFIQ-7 scores and a failure to reject the null hypothesis for our retrospective mesh 
augmented apical suspension cohort study.  
Anteroposterior GH widening during Valsalva maneuver likely represents an expanding 
defect or “hernia” through which a poorly supported apex descends, facilitating rather than 
obscuring vaginal wall descent. 
The “hernia” hypothesis is supported by an increasing volume of medical literature 
illustrating the crosswalk from vaginal delivery to pelvic organ prolapse via the following 
intermediary data sets: 1) vaginal delivery-associated levator ani muscle avulsion, 2) levator 
ani muscle avulsion-associated genital hiatal changes, and 3) genital hiatal change-associated 
pelvic organ prolapse.   
Vaginal delivery-associated levator ani muscle avulsion was identified by DeLancey et 
al.27 when they found a visible defect in the levator ani muscle on magnetic resonance images 
in 20% of primiparous women compared to none in the nulliparous group. Levator ani muscle 
avulsion 10 years following childbirth is almost tripled after forceps- compared to vacuum-
assisted vaginal delivery (OR 2.74, 95% CI 1.42, 13.62) as measured by transperineal 
ultrasonography.28 Vaginal parity is also significantly associated with widened GH on Valsalva, 
an effect that occurs mostly after the first delivery. This was evidenced by a marked increase in 
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mean GH area (cm2) between vaginal parity groups 0 (21.47, 95% CI 19.22, 23.72) and 1 
(29.05, 95%CI 26.83, 31.28), without further compromise for increasing parity. Levator 
avulsion as a plausible biologic mechanism was detected in 21% of four-dimensional 
translabial ultrasound.9   
Levator ani muscle avulsion-associated genital hiatal changes were identified by Shek 
et al. using four-dimensional translabial ultrasound. Levator avulsion 3-4 months after vaginal 
delivery was associated with a 28% increase in hiatal area during Valsalva compared to a 6% 
increase without levator avulsion.11 A retrospective study found that patients with levator 
avulsion (20.7%) diagnosed by transperineal ultrasound and signs of pelvic organ prolapse on 
examination (49.2%) had significantly larger hiatal areas compared to controls, thus 
“improv[ing] our understanding of the pathophysiology of pelvic organ prolapse as a form of 
hiatal hernia.”29  
Genital hiatal change-associated pelvic organ prolapse was identified by DeLancey et 
al. when they found larger hiatus areas (cm2), as measured by clinical biometry, associated 
with increased prolapse severity (grade 0, 5.4 ± 1.71; grade 1, 7.3 ± 1.91; grade 2, 8.3 ± 2.45; 
grade 3, 11.0 ± 4.90).15 In a prospective cohort study, patients with symptomatic pelvic organ 
prolapse were more likely than controls to have greater levator hiatal widths (mm) (40.3 ± 6.3 v 
25.7 ± 5.7) after controlling for age parity, and BMI.30 Similar to our findings, GH 
measurements (cm) during POP-Q examination increased through stage 3 disease (stage 0-1, 
2.74 ± 0.8; stage 2, 3.6 ± 1.0; stage 3, 4.83 ± 1.3), implicating GH as a marker of underlying 
pelvic muscle damage.31 
According to Yousef et al, levator ani muscle injury after vaginal delivery results in hiatal 
opening, predisposing to descent, “cystocele,” and exposure of the anterior vaginal wall to 
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pressure differentials. The increased pressure places mechanical stress on the distal 
connective tissue supports (uterosacral and cardinal ligaments) of the uterus and vagina. 
There is a strong linear relationship (r2 = 0.85) between hiatal diameter and exposed vaginal 
wall length. Apical suspension procedures eliminate the exposed length by repositioning the 
anterior vaginal wall such that it opposes and remains in contact with the posterior vaginal wall, 
effectively relieving added pressure differentials.26 
During posterior colpoperineorrhaphy, according to historical tenets, superficial side to 
side suturing of the fascia of the perineal musculature “will usually reconstitute the perineal 
body and draw the fascia of the pubococcygeal muscles closer to the upper lateral sides of the 
perineal body effectively narrowing the widened genital hiatus.”32  Reconstruction of the 
perineal body through posterior colpoperineorrhaphy is heralded as a necessary “feature of all 
operations designed to cure prolapse” because it 1) “restor[es] the normal bottle-neck shape to 
the lower end of the vagina,” 2) brings the posterior wall in contact with the lower end of the 
anterior wall, and 3) maintains the vagina’s “sharp forward curve,” along with the cardinal 
ligaments and levator ani muscle, protecting “against the tendency for the vagina to be turned 
inside out when the intraperitoneal pressure is raised.”33 
Though surgeries such as posterior colpoperineorrhaphy restore anatomy and reduce 
GH size, it remains unclear whether they prevent prolapse recurrence and positively influence 
pelvic floor function beyond what is already expected of apical suspension.31 Our study begins 
to fill this knowledge gap in providing surgical guidance regarding the need for concomitant 
posterior colporrhaphy during apical suspension for POP. Conventional LSCP and LSC with 
posterior colporrhaphy more than LSC without posterior colporrhaphy effectively narrowed a 
widened genital hiatus without positively or negatively affecting overall general pelvic floor or 
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colorectal specific symptom bother or impact on activities of daily living at 9-12 months 
postoperatively. Therefore, it is possible that 308 of 372 of our patients received concomitant 
procedures that provided no differential symptom benefit over conventional laparoscopic 
sacrocolpopexy alone other than improved vaginal topography. The prospective measurement 
of change in symptom severity and impact on activities of daily living in randomized study 
subjects undergoing mesh augmented apical suspension procedures with and without 
posterior colporrhaphy would be needed to test this hypothesis. 
Studies have demonstrated apical support through abdominal sacrocolpopexy 
regardless of posterior repair provides the anatomic success of improved posterior support,25,34 
but concomitant posterior repair possibly prevents recurrence of distal posterior prolapse. Yau 
et al. confirmed concomitant posterior colporrhaphy provides sustained improvement of POP-
Q point Ap, the most distal measurement of posterior vaginal support, at 34 months compared 
to no posterior repair.34 Whether sustained support results in improved posterior POP 
symptoms is unclear. Lack of randomization for concomitant posterior procedures leading to 
baseline differences in obstructive defecatory symptom severity precluded a definitive answer 
to the role of these procedures in symptom resolution one year after sacrocolpopexy.  In fact, 
patients with concomitant posterior procedures reported new bothersome bowel symptoms, 
including fecal incontinence with physical activity and pain prior to and with defecation 
compared to sacrocolpopexy alone25. 
Analysis of baseline and 5-year outcomes in the Extended Colpopexy And Urinary 
Reduction Efforts (E-CARE) trial demonstrated that regardless of preoperative posterior POP 
severity, anatomic success and decrease in defecatory symptoms are likely35 regardless of 
whether surgeons chose to perform concomitant posterior procedures (a choice driven by 
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presence of vaginal laxity or widened hiatus intraoperatively). However, recurrent posterior 
pelvic organ prolapse (12%) and retreatment (14%) rates were highest in patients who 
underwent concomitant posterior colporrhaphy at the time of sacrocolpopexy. Obstructed 
defecation symptom rates ranging from 17-19% were present 5 years after surgery regardless 
of preoperative POP severity or concomitant posterior procedure.35 Further prospective 
longitudinal studies, preferably randomized clinical trials,25,35 are recommended to validate the 
performance of LSCP or posterior colporrhaphy concurrently with LSC in providing differential 
anatomic outcomes or retreatment rates compared to LSC alone given this lack of symptom 
improvement.   
All of our studied prolapse procedures led to a decrease in preoperatively widened GH. 
The greatest decrease was seen in obliterative procedures, which is most likely due to the high 
perineorrhaphy performed in conjunction with vaginectomy with levator plication or LeFort 
colpocleisis resulting in a compensatory increase in PB size. The symptomatic, anatomic, and 
retreatment rate value of high perineorrhaphy in these patients is unclear. 
Our study has several limitations inherent in any retrospective study design.  Foremost 
is the lack of a definitive preoperative indication for posterior colporrhaphy. This limits our 
ability to provide evidence-based surgical guidance for the value of this procedure in 1) 
reducing symptom bother and impact on activities of daily living, 2) restoring vaginal 
topography, 3) or preventing recurrence given the short follow up for study patients25,35. In fact 
multiple indications to perform posterior colporrhaphy without levator plication as an adjunct to 
the primary procedure must have existed, as posterior colporrhaphy preceded LSCP while it 
followed LSC as deemed necessary for cosmetic effect. Postoperative data on symptom 
bother and impact of activities of daily living was present in only 33% of our surgical cohort, 
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decreasing our ability to detect a difference between surgical procedures if one truly exists.  
This limitation reduces the validity of stratified analyses including a comparison of symptoms 
attributable to posterior wall defects in the subset of patients with 24 month followup, or 
differential changes in symptom bother and impact on activities of daily living with or without 
posterior colporrhaphy by prolapse stage.  While it might be tempting to draw a clinical 
conclusion from the weak statistically significant correlation of delta GH with delta PFIQ-7, this 
finding is more likely the consequence of type I statistical error from multiple comparison 
testing following 20 test iterations absent other significant correlations.  Finally, differences in 
followup for vaginectomy with levator plication study subjects, while expected, provides a 
shorter time for reporting changes in symptom severity or impact on activities of daily living.  
Nonetheless, it is unlikely that these frail patients would report differential change compared to 
native tissue apical suspensions if longer followup was available given the findings from our 
study.  Strengths of our study include our large sample size and comparisons of multiple 
surgical procedures familiar to female pelvic medicine and reconstructive surgeons treating 
women with pelvic organ prolapse.  
Our clinical study contributes to the increasing body of medical evidence to supporting 
the “hernia” hypothesis during Valsalva’s maneuver. We are no longer concerned patients with 
POP and widened GH will be undertreated at a given vaginal length during Valsalva’s 
maneuver. Such patients have a higher baseline stage of prolapse and at least equally 
bothersome symptoms resulting from obstetric-related levator ani muscle damage compared to 
patients with non-widened GH measurements as defined in our study. Historical tenets 
purporting the value of a connective tissue repair for a skeletal muscle injury are not supported 
by our study or the growing body of medical evidence that apical suspensions alone restore 
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vaginal topography, reduce symptoms, and may prevent retreatment. Specifically, mesh-
augmented apical suspension with LSCP or LSC with posterior colporrhaphy without levator 
plication effectively reduced a widened GH without providing differential improvement in overall 
and colorectal-specific pelvic floor symptom bother and impact on activities of daily living 
compared to apical repair without posterior colporrhaphy. Prolapse recurrence is a reality for a 
percentage of patients and their surgeons because connective tissue repair is incapable of 
restoring obstetric-related levator ani muscle damage which persists despite short term 
anatomic restoration. Further studies examining the surgical impact on retreatment are needed 
to further qualify the value of performing posterior colporrhaphy prior to LSCP or following LSC 
beyond cosmesis. 
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Table 1 
Baseline characteristics of patients among the genital hiatus (GH) groups 
 GH ≤ 3 GH > 3 P value 
Age 59.6 ± 13.0 60.7 ± 12.3 0.43 
BMI 27.1 ± 5.9 29.3 ± 14.5 0.16 
Gravidity 3.1 ± 1.6 3.3 ± 1.6 0.34 
Parity 2.4 ± 1.3 2.8 ± 1.3 0.01 
BMI = Body mass index GH = Anteroposterior GH width (in cm) 
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Table 2 
 
Baseline evaluation of pelvic organ prolapse (POP) stage and leading edge (LE) within genital 
hiatus (GH) groups among total vaginal length (TVL) categories 
 
 Stage of POP Distribution Mean LE Edge 
Pre-op 
TVL 
GH < 3 GH > 3 P-value GH < 3 GH > 3 
P-value 
(mean diff, 95% CI) 
<10 cm 
n=134 
Stage 1 
8.7% 
Stage 2 
56.5% 
Stage 1 
0.9% 
Stage 2 
36.9% 
0.021 0.9 ± 1.4 2.8 ± 2.6 
<0.001 
(1.9, 95% CI 1.1, 2.6) Stage 3 
30.4% 
Stage 4 
4.3% 
Stage 3 
48.6% 
Stage 4 
13.5% 
10 cm 
n=288 
Stage 1 
8.9% 
Stage 2 
66.7% 
Stage 1 
1.2% 
Stage 2 
33.9% 
<0.001 0.4 ± 1.9 2.6 ± 2.5 
<0.001 
(2.2, 95% CI 1.4, 2.9) Stage 3 
24.4% 
Stage 4 
0.0% 
Stage 3 
55.8% 
Stage 4 
8.7% 
>10 cm 
n=189 
Stage 1 
10.7% 
Stage 2 
67.9% 
Stage 1 
1.2% 
Stage 2 
49.1% 
0.003 0.4 ± 1.7 1.9 ± 2.2 
<0.001 
(1.5, 95% CI 0.7, 2.4) Stage 3 
 
21.4% 
Stage 4 
 
0.0% 
Stage 3 
 
48.4% 
Stage 4 
 
1.2% 
 
TVL = Total vaginal length 
GH = Anteroposterior GH width (in cm) 
LE = Leading edge of prolapse (in cm) 
CI = Confidence interval 
POP = Pelvic organ prolapse  
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Table 3 
 
Baseline evaluation of PFDI -20 and PFIQ -7 within genital hiatus (GH) groups across pelvic 
organ prolapse (POP) stages 
 
 Mean PFDI-20 Mean PFIQ-7 
Stage of POP GH < 3 GH > 3 P-value GH < 3 GH > 3 P-value 
0, 1, and 2 
n=281 
113.4 ± 66.9 116.4 ± 58.7 0.737 85.2 ± 80.0 79.5 ± 62.9 0.958 
3 and 4 
n=335 
122.2 ± 68.2 109.0± 55.5 0.295 63.9 ± 67.5 67.3 ± 65.6 0.808 
GH = Anteroposterior GH width (in cm) 
POP = Pelvic organ prolapse 
PFDI-20 = Pelvic floor distress inventory 
PFIQ-7 = Pelvic floor impact questionnaire 
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Table 4 
Delta GH and Delta PB after mesh augmented apical suspension with and without posterior 
colporrhaphy 
 
LSCP 
N= 203 
LSC with posterior 
colporrhaphy 
N= 105 
LSC without posterior 
colporrhaphy 
N= 64 
P value 
 
Delta GH -2.1 ± 1.6* -2.0 ± 1.2** -1.3 ± 1.1 <0.001 
Delta PB 0.1 ± 1.5 0.3 ± 1.3 0.3 ± 1.1 0.371 
Mean Follow-up (mos) 11.4 ± 8.0 9.8 ± 6.4  9.4 ± 6.8 0.08 
Delta GH = Change in anteroposterior genital hiatus (postoperative – preoperative in cm) 
Delta PB = Change in anteroposterior perineal body (postoperative – preoperative in cm) 
LSCP = Laparoscopic sacrocolpoperineopexy 
LSC = Laparoscopic sacrocolpopexy 
 
*LSCP v LSC without posterior colporrhaphy, mean difference -0.9, p < 0.001 95%CI -0.4, -1.4 
**LSC with posterior colporrhaphy v LSC without posterior colporrhaphy, mean difference -0.8, p = 0.03 95%CI -0.2, -1.3 
 
 
 
 
 
 
 
 
 
29  
 
 
 
Table 5 
Delta GH and delta PB after prolapse surgery with posterior colporrhaphy 
 
LSC 
N =105 
LUSLS 
N = 36 
VUSLS 
N = 82 
Obliterative 
Approach 
N= 25 
P value 
 
Delta GH -2.0 ± 1.2 -1.5 ± 1.2 -1.5 ± 1.5 -3.5 ± 2.5*  <0.001 
Delta PB 0.3 ± 1.3 -0.1 ± 1.5 0.3 ± 1.7 1.3 ± 1.4** 0.002 
Mean Follow-up (mos) 9.8 ± 6.4 8.7 ± 6.3 10.0 ± 9.4 5.7 ± 4.4*** 0.01 
 
Delta GH = Change in anteroposterior genital hiatus (postoperative – preoperative in cm) 
Delta PB = Change in anteroposterior perineal body (postoperative – preoperative in cm) 
LSC = Laparoscopic sacrocolpopexy 
LUSLS = Laparoscopic uterosacral ligament suspension 
VUSLS = Vaginal uterosacral ligament suspension 
Obliterative approach = Vaginectomy with levator plication or LeFort Colpocleisis 
 
* Obliterative approach v LSC, mean difference -1.4, p < 0.001 95%CI -0.5, -2.3, Obliterative approach v LSUSLS, mean difference -1.9, p < 
0.001 95%CI -0.9, -3.0, Obliterative approach v VUSLS, mean difference -2, p < 0.001 95% CI -1.1, -2.9 
 
** Obliterative approach v LSC, mean difference 0.99, p = 0.14 95%CI 0.14, 1.85, Obliterative approach v LSUSLS, mean difference 1.4, p = 
0.001 95%CI 0.4, 2.4, Obliterative approach v VUSLS, mean difference 1.0, p = 0.01, 95%CI 0.2, 1.9 
 
*** Obliterative approach v LSC, mean difference -4.1, p = 0.013 95%CI -0.6, -7.7, Obliterative approach v VUSLS, mean difference -4.3, p = 
0.01 95%CI -0.7, -8.0 
  
 
